Blood coagulation

被引:91
作者
Norris, LA [1 ]
机构
[1] St James Hosp, Trinity Coll, Ctr Hlth Sci, Dept Obstet & Gynaecol,Coagulat Res Lab, Dublin 8, Ireland
关键词
coagulation; thrombin; fibrin; thrombosis;
D O I
10.1016/S1521-6934(03)00014-2
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Blood coagulation can be initiated by two pathways: the extrinsic pathway, which is triggered by release of tissue factor from the site of injury, and the intrinsic system, which is stimulated by contact with a negatively charged surface. Following initial triggering, a series of serine proteases are sequentially activated, culminating in the formation of thrombin, the enzyme responsible for the conversion of soluble fibrinogen to the insoluble fibrin clot. Activation of coagulation is tightly regulated. Initiation by tissue factor is inhibited by tissue factor pathway inhibitor. Antithrombin can inactivate many of the serine proteases, including thrombin, by forming stable complexes which are rapidly cleared from the circulation. Protein C and protein S combine to inactivate coagulation factors V and VIII. The deposition of excess fibrin is prevented by the fibrinolytic system which can lyse fibrin into fibrin degradation products. Both genetic and environmental factors can influence the activation of coagulation and may predispose affected individuals to thrombosis.
引用
收藏
页码:369 / 383
页数:15
相关论文
共 81 条
[1]
Amano K, 1998, THROMB HAEMOSTASIS, V79, P557
[2]
ENHANCING FIBRINOLYTIC ACTIVITY IN HUMAN BLOOD BY OCCLUSION OF BLOOD VESSELS .1. APPEARANCE OF PHENOMENON [J].
AMERY, A ;
VERSTRAETE, M ;
VERMYLEN, J ;
MAES, H .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1962, 7 (1-2) :70-&
[3]
INHIBITORS OF THE FIBRINOLYTIC ENZYME-SYSTEM [J].
AOKI, N ;
HARPEL, PC .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (01) :24-41
[4]
FACTOR-XI DEFICIENCY IN ASHKENAZI JEWS IN ISRAEL [J].
ASAKAI, R ;
CHUNG, DW ;
DAVIE, EW ;
SELIGSOHN, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :153-158
[5]
PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[6]
The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent [J].
Bajzar, L ;
Nesheim, ME ;
Tracy, PB .
BLOOD, 1996, 88 (06) :2093-2100
[7]
Activation markers of coagulation [J].
Bauer, KA .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (03) :387-406
[8]
MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[9]
Biguzzi E, 2001, THROMB HAEMOSTASIS, V86, P945